Hematologic malignancies
Clinical research includes multiple myeloma and acute myeloid leukemia, with interest in CD19-directed cellular therapy, bispecific antibodies, and combinations used in patients with relapsed or newly diagnosed disease.
- Multiple myeloma
- Acute myeloid leukemia
- CAR-T cell therapy
- CD19-targeted treatment
Work in this area also reflects attention to frail and older patients needing less intensive treatment options.
Neurology and cerebrovascular disease
The sponsor studies Alzheimer’s disease, Parkinson’s disease, stroke, and intracerebral haemorrhage, alongside research on cognitive decline, motor fluctuation, and post-hemorrhagic brain injury.
- Alzheimer’s disease
- Parkinson’s disease
- Stroke
- Intracerebral haemorrhage
Its neurological portfolio also includes approaches related to dopaminergic stimulation and recovery after brain bleeding.
Respiratory and thoracic oncology
Research activity covers chronic obstructive pulmonary disease, advanced non-small-cell lung cancer, and malignant pleural mesothelioma, with interest in both symptom control and treatment-resistant thoracic cancer.
- COPD
- Non-small-cell lung cancer
- Malignant pleural mesothelioma
- Immunotherapy
These studies indicate involvement in pulmonary function assessment and combined local and systemic cancer treatment strategies.
Dermatology and rare mucocutaneous disease
Trials address actinic keratosis and vulvar extramammary Paget’s disease, with additional work in cervico-facial lymphatic malformations that require specialized local therapy.
- Actinic keratosis
- Extramammary Paget’s disease
- Lymphatic malformations
- Photodynamic therapy
The dermatologic and rare disease portfolio includes lesions affecting the scalp, forehead, vulva, and cervico-facial region.
Inflammatory, hepatic, and urologic disorders
Additional research focuses on alcoholic hepatitis, polycystic ovary syndrome, and neuro-urology in patients with multiple sclerosis or spinal cord injury.
- Alcoholic hepatitis
- Polycystic ovary syndrome
- Detrusor overactivity
- Multiple sclerosis
This area also includes management of urinary complications associated with impaired bladder control and chronic neurological disease.
